Ezetimibe oral tablet is available as a generic drug and a brand-name drug. Brand name: Zetia. Ezetimibe comes only as a tablet you take by mouth. Ezetimibe oral tablet is used to reduce high ...

Please provide your email address to receive an email when new articles are posted on . It is well known that HMG-CoA reductase inhibitors reduce LDL, a surrogate marker in atherosclerotic disease, as ...

Are you taking Ezetimibe? Are you aware of the dangers of combining Ezetimibe with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

This retrospective study strongly suggests that splitting a 10-mg ezetimibe tablet yields a 5-mg dose that is clinically equivalent to the 10-mg dose. Objective: To compare the clinical efficacy of ...

Please provide your email address to receive an email when new articles are posted on . Althera announced the FDA approved its rosuvastatin/ezetimibe tablets as an adjunct to diet for treatment of ...

Learn everything you need to know about Ezetimibe and Simvastatin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, ...

LONDON — A new analysis of the IMPROVE-IT trial indicates that the nonstatin, cholesterol-lowering drug ezetimibe (Zetia, Merck) is of specific benefit in patients with acute coronary syndrome who ...

Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal ...

A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...

The appraisal committee reviewed the data available on the clinical and cost effectiveness of ezetimibe, having considered evidence on the nature of primary heterozygous‑familial and non‑familial ...